Canadian Cardiovascular Society

Lipid screening is a key component of risk assessment for primary prevention of atherosclerotic cardiovascular disease (ASCVD). More than one-quarter of Canadians with high cholesterol do not know that they have unhealthy lipid levels.

On April 10, the Canadian Cardiovascular Society (CCS) launched a national lipid screening awareness campaign to encourage people at risk of ASCVD to get their cholesterol, triglycerides, and Lp(a) levels tested and seek support from their healthcare provider. Digital ads are driving people who are at risk to a self-management tool that helps them understand and track their lipid test results, while ongoing social media posts, e-newsletters, and CCS stakeholder engagement activities are further disseminating the campaign’s key messages and reach.

Kindly support this campaign by: 

Lastly, support the campaign by reviewing the 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. They support meaningful conversation and shared decision-making between patient and healthcare provider, so that individual care plans can be made for risk screening, assessment, and treatment. The 2021 CCS Guidelines recommend that lipid screening include total cholesterol (TC), LDL-C, HDL-C, non-HDL-C, triglycerides (TG), as well as once in a lifetime lipoprotein(a) [Lp(a)] measurement and optional assessment of ApoB as part of a comprehensive risk assessment of ASCVD.

Back to top